zaleplon

CHEBI:CHEBI_10102

Definition

A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position.

Chemical Information

Molecular Formula
C17H15N5O
Molecular Mass
305.33390
Charge
0
SMILES
CCN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C#N
InChI
InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3
InChIKey
HUNXMJYCHXQEGX-UHFFFAOYSA-N

Alternative Names

  • 3'-(3-Cyanopyrazolo(1,5-a)pyrimidin-7-yl)-N-ethylacetanilide
  • N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide
  • zaleplon

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
74667
oboInOwl#hasDbXref
Wikipedia:Zaleplon
core#notation
CHEBI:10102

Additional References

Wikipedia:Zaleplon

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

DRON_00010000
74667
oboInOwl#hasDbXref
Wikipedia:Zaleplon
oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#id
CHEBI:10102
generic_name
ZALEPLON
brand_name
ZALEPLON
brand_name_base
ZALEPLON
product_type
BULK INGREDIENT
listing_expiration_date
20241231
marketing_category
BULK INGREDIENT
dosage_form
CAPSULE
labeler_name
Bionpharma Inc.
marketing_start_date
20090505
product_ndc
50090-1564
spl_id
b6f10404-69b2-47b0-970e-bf392d4a6ebd
application_number
ANDA090374
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_35717
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
route
ORAL
package_ndc
50090-1564-1
package_description
30 CAPSULE in 1 BOTTLE (50090-1564-1)
rxcui
313762
active_ingredient_strength
50 kg/50kg
manufacturer_name
Bionpharma Inc.
nui
N0000175728
package_marketing_start_date
06-JUN-08
active_ingredient_name
ZALEPLON
unii
S62U433RMH
spl_set_id
8276a418-6a4c-4b81-8170-2d3838576c6d
upc
0343063783108
core#notation
CHEBI:10102
dea_schedule
CIV
pharm_class_moa
GABA A Agonists [MoA]
pharm_class
gamma-Aminobutyric Acid A Receptor Agonist [EPC]
pharm_class_pe
Central Nervous System Depression [PE]
pharm_class_epc
gamma-Aminobutyric Acid A Receptor Agonist [EPC]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect1409
owl#annotatedSource
t92927
owl#someValuesFrom
t840747